Q2/ 2022. However, the reason for the increase in revenue because the company having increased sales and being able to operate at full capacity and fully exportable Cost of Sales for Q2 / 2023 and Q2
foreign exchange gains compared to US dollars. (Which is the main trading currency of the company) Cost of Sales for Q3/2023 and Q3/2022 was 696.59 million baht and 509.25 million baht, respectively. It is
534.81 million baht, respectively an increase of 48.31 million baht, or 9.93 percent. Cost of Sales for Q2 / 2024 and Q2 / 2023 was 393.00 million baht and 650.25 million baht, respectively. Decreased by
and administrative expenses, bad debt and doubtful accounts, and finance cost. In the fiscal year ended February 28, 2019, the Company had total consolidated expenses of 16,213 million baht, increased
in 3Q19 was Bt143.78mn, decreasing 1.1% YoY and 1.0% QoQ, as a result of decreasing in financial cost and tax expense, kiosk improvement to support new business, and fully-depreciated kiosk maintenance
price lag in HVA fibers and normalizing IPA margins. Production increased 14% YoY to 2.7 million tons especially from new assets in Brazil and Portugal. Higher crude oil prices and raw material cost
project equaled to Baht 558,583,482, comprising of Land in amount of Baht 218,000,000, construction cost, system work and medical equipment/ supplies in amount of Baht 340,583,482 5. Price Determination
% 3,147.35 100.0% -5.7% Cost of services (652.92) -79.7% (622.36) -79.7% (599.48) -78.4% -3.7% -8.2% (2,631.21) -78.7% (2,491.76) -79.2% -5.3% Gross profit 166.35 20.3% 157.80 20.2% 164.86 21.6% 4.5% -0.9
last year due to the high cost of new business "Wuttisak Clinic". Compare with revenues that occurred in the first quarter of 2018, such as medical services costs, costs of tools and equipment include
period of the previous year were as highlighted below ; (Unit : Million Baht) Q3/2017 Q3/2016 % Change Sales and Service Income 514.22 465.84 +4.66 Cost of sales and Services 398.23 336.98 +3.01 Selling